What Is Chronic Migraine? Diagnostic Criteria and Treatment Options

There is episodic migraine, and then there is chronic migraine. The distinction matters enormously to the people living with it, to the clinicians treating it, and to insurers deciding what to cover. Yet chronic migraine remains widely misunderstood, frequently misdiagnosed, and undertreated at a rate that researchers have described as a public health problem.

Understanding what chronic migraine is, how it is diagnosed, and what treatment options exist is essential for anyone whose headache calendar has started to look more full than empty.

Defining Chronic Migraine

The International Headache Society defines chronic migraine as headache occurring on fifteen or more days per month for more than three months, with at least eight of those days meeting criteria for migraine or responding to migraine-specific treatment.

That definition contains an important nuance. Not every headache day needs to be a full migraine attack to count toward the threshold. A person can experience fifteen headache days per month, with eight of those being clear migraines and the rest being milder headaches, and still meet the diagnostic criteria. This reflects the clinical reality that people with chronic migraine often experience a spectrum of headache severity across the month rather than identical attacks every time.

Episodic migraine, by contrast, is defined as fewer than fifteen headache days per month. The boundary between the two is not a sharp biological line. It is a clinical threshold that helps guide diagnosis and treatment decisions.

How Episodic Migraine Becomes Chronic

Chronic migraine does not typically appear out of nowhere. In most cases it evolves from episodic migraine through a process called transformation or chronification. Understanding what drives that process matters because some of the factors involved are modifiable.

Medication overuse is one of the most well-documented drivers of chronification. People who use acute pain relief medications, including triptans, over the counter analgesics, and opioids, on ten or more days per month are at risk of developing medication overuse headache, a condition in which the medication itself begins to perpetuate and worsen the headache cycle. The American Headache Society considers medication overuse one of the most important and preventable contributors to the development of chronic migraine.

Other risk factors for chronification include obesity, sleep disorders, depression and anxiety, stressful life events, and caffeine overuse. Genetic predisposition also plays a role. Not everyone with episodic migraine will develop chronic migraine, but people with high attack frequency, strong attack severity, and the presence of these additional risk factors are at greater risk.

The Burden of Chronic Migraine

The consequences of that progression are significant. Research published in the journal Headache has found that people with chronic migraine report significantly greater impact on work productivity, daily functioning, and quality of life than those with episodic migraine. The condition is associated with higher rates of depression, anxiety, and sleep disorders, and it places a disproportionate economic burden on individuals and healthcare systems.

A study using data from the American Migraine Prevalence and Prevention Study found that fewer than five percent of people with chronic migraine were receiving preventive treatment at the time of survey, despite the fact that all of them met criteria for it. That gap between need and treatment represents a significant missed opportunity for the people most severely affected by the condition.

Diagnosis

Chronic migraine is a clinical diagnosis. There is no blood test or imaging study that confirms it. Diagnosis relies on a careful headache history, ideally supported by a detailed migraine diary that documents headache frequency, duration, severity, and associated symptoms over at least one month, and preferably three.

Neurologists and headache specialists use the ICHD-3 diagnostic criteria as the framework for diagnosis. They will also evaluate for medication overuse, secondary headache causes, and comorbid conditions that may be contributing to the headache burden. Brain imaging is not routinely necessary for diagnosing chronic migraine but may be ordered to rule out secondary causes when the clinical picture warrants it.

Accurate diagnosis is the foundation of effective treatment. People who are diagnosed with chronic tension headache when they actually have chronic migraine, or who are not diagnosed at all, are unlikely to receive treatments that target the correct underlying mechanisms.

Treatment Options

Treatment for chronic migraine generally involves two parallel strategies. The first is acute treatment, medication taken during an attack to reduce its severity and duration. The second is preventive treatment, medication or other interventions taken regularly to reduce the frequency, severity, and duration of attacks over time.

Preventive treatment is strongly recommended for anyone who meets the criteria for chronic migraine. Options include oral medications such as topiramate, valproate, amitriptyline, and beta blockers, all of which have established evidence for migraine prevention. Onabotulinumtoxin A, marketed as Botox, is approved specifically for the prevention of chronic migraine and has demonstrated effectiveness in multiple large clinical trials.

The newest class of preventive treatments, anti-CGRP monoclonal antibodies including erenumab, fremanezumab, galcanezumab, and eptinezumab, represent a significant advance. They were developed specifically for migraine prevention, they are generally well tolerated, and they have shown meaningful reductions in monthly headache days in clinical trials involving people with chronic migraine. Several are administered monthly or quarterly by injection or infusion.

Behavioral and lifestyle interventions also play a meaningful role. Regular sleep, consistent meal timing, adequate hydration, stress management, and moderate aerobic exercise have all been shown to support migraine prevention. Cognitive behavioral therapy has evidence for reducing migraine frequency and improving quality of life in people with chronic migraine.

For people with medication overuse, withdrawing the overused medication is often a necessary first step before preventive treatment can be effective. This process is best done under medical supervision.

The Importance of Ongoing Tracking

Chronic migraine is a condition that changes over time. Attack frequency, severity, and treatment response can all shift. Keeping a detailed record of headache days, medications used, and associated symptoms is not just useful at the point of diagnosis. It is essential for monitoring treatment effectiveness, identifying emerging medication overuse, and making the case for treatment adjustments when they are needed.

A neurologist making decisions about preventive therapy needs to know whether a treatment is working. Without data, that assessment is a guess. With a well-kept diary, it is an informed clinical decision.